TR200001040T2 - Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı - Google Patents
Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımıInfo
- Publication number
- TR200001040T2 TR200001040T2 TR2000/01040T TR200001040T TR200001040T2 TR 200001040 T2 TR200001040 T2 TR 200001040T2 TR 2000/01040 T TR2000/01040 T TR 2000/01040T TR 200001040 T TR200001040 T TR 200001040T TR 200001040 T2 TR200001040 T2 TR 200001040T2
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- new use
- itch effect
- itch
- effect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Kasinti olusturan hastaliklarin veya rahatsizliklarin önleme veya tedavisinde kullanilan 8-baska maddelerle degistirilmis iksantinlerin türevleri
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6374697P | 1997-10-17 | 1997-10-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200001040T2 true TR200001040T2 (tr) | 2001-01-22 |
Family
ID=22051225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/01040T TR200001040T2 (tr) | 1997-10-17 | 1998-10-16 | Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1030666A4 (tr) |
JP (1) | JP2001520196A (tr) |
KR (1) | KR20010031149A (tr) |
CN (1) | CN1306426A (tr) |
AR (1) | AR015966A1 (tr) |
AU (1) | AU740875B2 (tr) |
BR (1) | BR9814080A (tr) |
CA (1) | CA2306985A1 (tr) |
CO (1) | CO4810374A1 (tr) |
CZ (1) | CZ20001376A3 (tr) |
HU (1) | HUP0003792A3 (tr) |
IL (1) | IL135581A0 (tr) |
NO (1) | NO20001847D0 (tr) |
NZ (1) | NZ503551A (tr) |
PL (1) | PL341062A1 (tr) |
TR (1) | TR200001040T2 (tr) |
WO (1) | WO1999020280A1 (tr) |
ZA (1) | ZA989450B (tr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60113731T2 (de) | 2001-01-31 | 2006-06-29 | Pfizer Products Inc., Groton | Als inhibitoren von pde4-isozymen geeignete etherderivate |
US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
SK8792003A3 (en) | 2001-01-31 | 2004-09-08 | Pfizer Prod Inc | Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes and pharmaceutical composition containing them |
EA200300622A1 (ru) | 2001-01-31 | 2003-12-25 | Пфайзер Продактс Инк. | Производные амидов тиазолил-, оксазолил, пирролил- и имидазолилкислот, полезные в качестве ингибиторов изоферментов pde4 |
US20030175314A1 (en) * | 2001-11-19 | 2003-09-18 | Didriksen Erik Johannes | Pharmaceutical composition for dermal application |
TW200503709A (en) * | 2003-07-17 | 2005-02-01 | Santen Pharmaceutical Co Ltd | Itching treating agent containing piperidine derivative as active ingredient |
JP2005187458A (ja) * | 2003-12-04 | 2005-07-14 | Santen Pharmaceut Co Ltd | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
WO2005053672A1 (ja) * | 2003-12-04 | 2005-06-16 | Santen Pharmaceutical Co., Ltd. | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
CN101103030B (zh) | 2004-02-14 | 2010-10-13 | 史密丝克莱恩比彻姆公司 | 具有hm74a受体活性的药物 |
JP2008137892A (ja) * | 2005-03-04 | 2008-06-19 | Eisai Co Ltd | 止痒剤 |
ATE487719T1 (de) | 2005-08-10 | 2010-11-15 | Glaxosmithkline Llc | Xanthinderivate als selektive hm74a-agonisten |
TWI404709B (zh) * | 2006-02-21 | 2013-08-11 | Eisai R&D Man Co Ltd | 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives |
AU2007218725B2 (en) * | 2006-02-21 | 2011-12-01 | Eisai R & D Management Co., Ltd. | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
WO2008099887A1 (ja) | 2007-02-16 | 2008-08-21 | Eisai R & D Management Co., Ltd. | メチル n-[3-(6,7-ジメトキシ-2-メチルアミノキナゾリン-4-イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩 |
CN101687819B (zh) | 2007-08-17 | 2013-03-20 | 卫材R&D管理有限公司 | 外用剂 |
ATE538102T1 (de) | 2007-08-17 | 2012-01-15 | Eisai R&D Man Co Ltd | Verfahren zur herstellung eines chinazolinderivats |
EP2727594B1 (en) | 2011-06-28 | 2017-12-20 | Mitsubishi Tanabe Pharma Corporation | Naphtalene compounds to treat itch |
EA034139B1 (ru) | 2015-01-30 | 2020-01-09 | Шаньтонь Фарма Ко., Лтд. | Профилактика или лечение мочекислых или подагрических заболеваний |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06504534A (ja) * | 1990-12-21 | 1994-05-26 | ビーチャム・グループ・パブリック・リミテッド・カンパニー | キサンチン誘導体 |
JP4141501B2 (ja) * | 1996-03-26 | 2008-08-27 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規の6位置換フェナントリジン |
PT912568E (pt) * | 1996-05-15 | 2003-04-30 | Altana Pharma Ag | Imidazopiridinas |
US6143759A (en) * | 1997-03-07 | 2000-11-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrazoles |
CN1269722A (zh) * | 1997-03-18 | 2000-10-11 | Basf公司 | 调节对皮质类固醇反应的方法及组合物 |
US6384047B1 (en) * | 1997-06-03 | 2002-05-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
-
1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/es not_active Application Discontinuation
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 CO CO98060225A patent/CO4810374A1/es unknown
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/ko not_active Application Discontinuation
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/cs unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/pt not_active IP Right Cessation
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/tr unknown
- 1998-10-16 IL IL13558198A patent/IL135581A0/xx unknown
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 PL PL98341062A patent/PL341062A1/xx unknown
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/hu unknown
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Application Discontinuation
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/ja not_active Withdrawn
- 1998-10-16 ZA ZA989450A patent/ZA989450B/xx unknown
- 1998-10-16 CN CN98810066A patent/CN1306426A/zh active Pending
-
2000
- 2000-04-10 NO NO20001847A patent/NO20001847D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA989450B (en) | 1999-04-19 |
CA2306985A1 (en) | 1999-04-29 |
BR9814080A (pt) | 2000-09-26 |
HUP0003792A2 (hu) | 2001-10-28 |
EP1030666A1 (en) | 2000-08-30 |
EP1030666A4 (en) | 2002-10-16 |
AR015966A1 (es) | 2001-05-30 |
CZ20001376A3 (cs) | 2002-06-12 |
WO1999020280A1 (en) | 1999-04-29 |
IL135581A0 (en) | 2001-05-20 |
AU1093899A (en) | 1999-05-10 |
NO20001847L (no) | 2000-04-10 |
JP2001520196A (ja) | 2001-10-30 |
AU740875B2 (en) | 2001-11-15 |
CO4810374A1 (es) | 1999-06-30 |
PL341062A1 (en) | 2001-03-26 |
KR20010031149A (ko) | 2001-04-16 |
CN1306426A (zh) | 2001-08-01 |
NZ503551A (en) | 2002-05-31 |
HUP0003792A3 (en) | 2001-12-28 |
NO20001847D0 (no) | 2000-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200001040T2 (tr) | Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı | |
TR200103233T2 (tr) | Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri. | |
CY1105144T1 (el) | Χρηση μιας ουσιας που συνδεεται στον πepιφepειακο υποδοχεα των βενζοδιαζεπινων στη θepαπεια του δepματικου στρες | |
ES2060310T3 (es) | Utilizacion de la n-miristoil-(s)-fenilalanina para la obtencion de medicamentos destinados al tratamiento de enfermedades que hacen intervenir la miristoilacion. | |
EA200300628A1 (ru) | Соединения, специфические к аденозиновому a, aи aрецептору, и их применение | |
PT797439E (pt) | Utilizacao de pramipexote como agente neuroprotector | |
TR199800815A2 (tr) | Sülfonilaminokarbonasitler. | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
ES2192839T3 (es) | Timosina beta 4 oxidada. | |
PL323490A1 (en) | Tetralinic compounds exibiting acitity against multgiple-drug refractoriness | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
TR199800270T1 (tr) | Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi. | |
HRP20090336T1 (en) | Antitumor combinations containing vegf - trap and 5fu or one of its derivatives | |
TR200101722T2 (tr) | Serivastatin ve fibratların birleşimi. | |
SE9802937D0 (sv) | Novel compounds | |
TR199802351T2 (tr) | Topikal kullanim için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bilesimi. | |
ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
TR199900505T2 (tr) | ||
MY113092A (en) | Cisapride extended release | |
DE69901805T2 (de) | Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin | |
BR0313230A (pt) | Uso de carboxamidas para o tratamento de tinido | |
TR199801798T2 (tr) | Otizm tedavisi. | |
PT869785E (pt) | 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
ES2150418T3 (es) | Composiciones farmaceuticas que comprenden calcitonina. |